Research published in Scientific Reports journal has suggested that botulinum toxin (BoNT-A) could be used as an effective treatment for patients with depression.
International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
A study published by the Journal of Investigative Dermatology has revealed promising results for a new vaccine that could prevent acne vulgaris.
The British Association of Cosmetic Nurses (BACN) has opened its academic poster submission for its Autumn Aesthetic Conference on November 8 and 9 in Birmingham.
Aesthetic product supplier CACI International has released new statistics following a clinical study that took place on 25 female participants trialing the new Simultaneous Photo Electrical Delivery (S.P.E.D) technology.
A recent UK study suggests that there are a 20 genetic markers that appear to be linked with tanning of the skin.
Following the launch of the Advanced Perfecting Shield SPF30 earlier this year, global aesthetic manufacturer Teoxane has released clinical studies and evidence aimed to support the efficacy of the product.
A study published in the American Journal of Clinical Nutrition has indicated that vitamin D2 and D3 do not have the same nutritional value.
A new drug has been developed that aims to mimic sunlight and cause the skin to tan without the damaging effects of UV radiation.
Global pharmaceutical company Allergan and biopharmaceutical company Paratek have confirmed that two phase 3 trials of sarecycline met their 12-week primary efficacy endpoints.